2015 - Proteases at the cutting edge: friends or foes in chronic lung diseases?

Days (1)

ALL

Tuesday, 21.06.2016

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Access older content

2019 - Targeting the detrimental effects of sleep disturbances and disorders ? towards personalized treatment in respiratory diseases

2018 - Lung Cancer Screening: from Trial to Practice

2018 - The impact of air pollution on respiratory health ? a focus on persistent problems and new emerging areas

2017 - Immunotherapy: a new standard of care in thoracic malignancies?

2017 - Integrating systems biology approach in idiopathic pulmonary fibrosis research

2017 - Precision medicine in airway diseases

2016 - Pulmonary vascular endothelium: orchestra conductor in respiratory diseases - highlights from basic research to therapy

2016 - New developments in in vitro models of the pulmonary epithelium

2016 - Challenges in respiratory medicine: how can we move from symptomatic management to a cure

2015 - Genetics, epigenetics and exposomics: novel methods to study gene-by-environment interactions

2015 - ERS Presidential Summit on personalising respiratory care in Europe

2015 - Targeted therapy for lung cancer

2015 - IPF and cancer: wounds that do not heal

2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

2014 - ERS Presidential Summit on breaking down barriers to lung health

2014 - The many faces of stem cells in respiratory diseases

2014 - Protein quality control in lung disease

2013 - Translational animal models of asthma

2013 - Optimising models for human lung diseases and drug development

2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research

2013 - Sensational developments in the airways: The role of afferent hyper and hypo function in respiratory disease

2012 - Pulmonary inflammation in paediatric respiratory disease

2012 - Dyspnoea: multidimensional and multidisciplinary

2012 - ERS Summit on bridging the health divide in Europe

2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

2011 - Physical activity, nutritional status and systemic inflammation in COPD

2011 - ERS Summit on priorities in respiratory medicine

2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

2010 - The role of small airways in obstructive pulmonary diseases

2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

2009 - International seminar on the rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)

2009 - Molecular and Cellular aspects of Chronic Lung Disease

2008 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge

2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases

2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension

2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

2007 - The limits to exercise in COPD: new insights from new methods

2007 - Severe Asthma

2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening

2006 - Complexity of patients with multiple chronic diseases

2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

2005 - Tobacco Smoking: Harm Reduction Strategies

2005 - Smoke Free Europe Conference 2005, jointly organised by ECL, EHN, ERS, French League against Cancer and Cancer Research UK

2005 - Adaptations to Hypoxia

2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases

2004 - The bronchial smooth muscle in airway responsiveness

2010 - Managing the lung of the extremely low gestational age neonate (ELGAN) in the delivery room

2021 - Unravelling severe exacerbations of COPD ? CICERO an ERS CRC

2021 - Lung function trajectories from birth to death, health and disease, and pre-war to today

2022 - Pharmacology of asthma and COPD: current and future developments

Localizing the proteolytic activity: lysosomal and extracellular Cystein cathepsins

B. Turk (Ljubljana, Slovenia)

Slides

Accompanying documents

The role of Proteases in CF lung Disease

M. Mall (Heidelberg, Germany)

Accompanying documents

Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence

M. Si-Tahar (Tours, France)

Slides

Accompanying documents

Emerging roles of human cysteine proteases in fibrosis and infection

G. Lalmanach (Tours, France)

Accompanying documents

Proteases as tools for diagnosis and novel therapeutics

S. Meiners (München, Germany)

Slides

Accompanying documents

2015 - Proteases at the cutting edge: friends or foes in chronic lung diseases?

2015 - Proteases at the cutting edge: friends or foes in chronic lung diseases?

#{title}